{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:26:23Z","timestamp":1775064383509,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1136\/ijgc-2022-004184","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T09:50:10Z","timestamp":1671097810000},"page":"175-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Best original research presented at the 23rd European Congress on Gynaecological Oncology\u2014Best of ESGO 2022"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2539-3894","authenticated-orcid":false,"given":"Joanna","family":"Kacperczyk-Bartnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1727-904X","authenticated-orcid":false,"given":"Nicol\u00f2","family":"Bizzarri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4401-3084","authenticated-orcid":false,"given":"Martina Aida","family":"Angeles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3943-5971","authenticated-orcid":false,"given":"Charalampos","family":"Theofanakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9769-7240","authenticated-orcid":false,"given":"Alexander B","family":"Shushkevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8749-4642","authenticated-orcid":false,"given":"Aleksandra Natalia","family":"Strojna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Pletnev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Nikolova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3799-3539","authenticated-orcid":false,"given":"Jonathan","family":"Ledermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignace","family":"Vergote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2022-004184_bb0010","unstructured":"Living with Ovarian Cancer Website . Available: https:\/\/ovarian.gynecancer.org\/ [Accessed on 14th November 2022]."},{"key":"10.1136\/ijgc-2022-004184_bb0015","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/IGC.0000000000001282","article-title":"Report from the 20th meeting of the European Society of Gynaecological Oncology (ESGO 2017)","volume":"28","author":"Zalewski","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0020","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/ijgc-2020-001226","article-title":"Report from the 21st meeting of the European Society of Gynaecological Oncology (ESGO 2019)","volume":"30","author":"Bizzarri","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0025","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/ijgc-2021-002577","article-title":"Report from the European Society of Gynaecological Oncology (ESGO) 2020 state-of-the-art virtual meeting","volume":"31","author":"Razumova","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2022-003593","article-title":"22Nd meeting of the European Society of Gynaecological Oncology (ESGO 2021) report","volume":"32","author":"Razumova","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0035","first-page":"A1","article-title":"ESGO 2022 Congress","volume":"32","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0040","article-title":"2022-RA-1219-ESGO\u2005SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer","volume":"32","author":"Boria","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0045","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/ijgc-2022-003790","article-title":"SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer","volume":"32","author":"Boria","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0050","article-title":"2022-RA-827-ESGO\u2005Sentinel node biopsy diminishes the use of adjuvant therapy in women with early cervical cancer in the SUCCOR cohort","volume":"32","author":"G\u00f3mez","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0055","first-page":"A32","article-title":"2022-RA-908-ESGO\u2005The importance of pathological ultrastaging for sentinel lymph node biopsy in cervical cancer, the final outcome of the Sentix study (CEEGOG-CX01; ENGOT-CX2;)","volume":"32","author":"Kocian","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0060","article-title":"2022-RA-959-ESGO\u2005Pelvic sentinel lymph node distribution; the final outcome of the Sentix trial (CEEGOG-CX01; ENGOT-CX2;)","volume":"32","author":"Kocian","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0065","article-title":"2022-RA-689-ESGO\u2005Fertility-sparing treatment in patients with IB1 cervical cancer \u2013 results of the international multicentre retrospective FERTISS study (ENGOT Cx14; CEEGOG Cx-03)","volume":"32","author":"Slama","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0070","first-page":"A30","article-title":"2022-RA-878-ESGO\u2005Robotic-assisted versus vaginal radical trachelectomy in patients with cervical cancer. Radicality, recurrence-free survival and cancer-specific mortality","volume":"32","author":"Soltanizadeh","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0075","article-title":"2022-RA-205-ESGO\u2005Circulating HPV DNA in cervical cancer: a marker for early detection of relapse","volume":"32","author":"Jeannot","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0080","first-page":"A388","article-title":"2022-RA-1605-ESGO\u2005Precision-predicting risk of endometrial cancer in asymptomatic women","volume":"32","author":"Kitson","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0085","first-page":"A119","article-title":"2022-RA-925-ESGO\u2005Development of adjuvant treatment decision support tool for endometrial cancer patients by pooled analysis of data from 2000 women included in the PORTEC-1\u20133 trials and a prospective cohort study","volume":"32","author":"Vermij","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0090","first-page":"A95","article-title":"2022-RA-450-ESGO\u2005Benefit of adjuvant radiotherapy depends on molecular class of early-stage endometrial cancer","volume":"32","author":"Horeweg","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0095","article-title":"2022-RA-653-ESGO\u2005The impact of histology, prior therapy, and dMMR status on lenvatinib + pembrolizumab outcomes in patients with advanced endometrial cancer: a subgroup analysis of study 309\/KEYNOTE-775","volume":"32","author":"Lorusso","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0100","article-title":"2022-RA-1276-ESGO\u2005Pembrolizumab monotherapy for advanced clear cell gynaecological cancer: phase II PEACOCC trial","volume":"32","author":"Miller","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0105","article-title":"2022-RA-683-ESGO\u2005The ENSURE trial for women with early-stage endometrial cancer: a randomized controlled trial comparing the effect of a reduced versus usual follow-up schedule on patient satisfaction, health care use, and disease perceptions","volume":"32","author":"Ezendam","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0110","article-title":"2022-RA-825-ESGO\u2005The impact of age on prognosis in women with endometrial cancer: a pooled analysis of the PORTEC-1, -2 and -3 randomised trials","volume":"32","author":"Wakkerman","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0115","first-page":"A412","article-title":"2022-RA-1136-ESGO\u2005A single-cell map of rare ovarian cancer","volume":"32","author":"Laga","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0120","article-title":"2022-RA-894-ESGO\u2005Endometrioid ovarian carcinoma \u2013 real world evidence from a large transatlantic team initiative: first results of the LEOPARD study","volume":"32","author":"Grube","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0125","first-page":"A227","article-title":"2022-RA-276-ESGO\u2005Value of surgical cytoreduction for subsequent ovarian cancer relapse in patients previously treated with chemotherapy alone at 1st-relapse: a subanalysis of the DESKTOP III\/ENGOT-ov20 trial","volume":"32","author":"Fotopoulou","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0130","first-page":"A273","article-title":"2022-RA-884-ESGO\u2005Whole-body diffusion-weighted MRI (WB-DWI\/MRI) for the prediction of resectable disease at the time of secondary cytoreductive surgery for relapsed epithelial ovarian cancer","volume":"32","author":"Dumont","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0135","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(17)32440-6","article-title":"Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"Coleman","year":"2017","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2022-004184_bb0140","article-title":"2022-RA-249-ESGO\u2005Overall survival results from ariel3: a phase 3 randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma","volume":"32","author":"Coleman","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0145","first-page":"A238","article-title":"2022-RA-567-ESGO\u2005The Geneva HRD test: clinical validation on 469 samples from the PAOLA-1 trial","volume":"32","author":"Christinat","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0150","article-title":"2022-RA-873-ESGO\u2005Validation study of the \u2018NOGGO-GIS ASSAY\u2019 based on ovarian cancer samples from the first-line PAOLA-1\/ENGOT-ov25 phase-III trial","volume":"32","author":"Willing","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0155","article-title":"Impact of surgery and chemotherapy timing on outcomes in older versus younger epithelial ovarian cancer patients: a nationwide Danish cohort study","volume":"32","author":"Ekmann-Gade","year":"2022","journal-title":"J Geriatr Oncol"},{"key":"10.1136\/ijgc-2022-004184_bb0160","first-page":"A395","article-title":"Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: results from the randomized SCORPION trial","volume":"32","author":"Marchetti","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0165","article-title":"Clinical and survival data of early-stage tubo-ovarian carcinoma according to BRCA mutational status. A large, multicenter, retrospective study","volume":"32","author":"Marchetti","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0170","first-page":"A319","article-title":"2022-RA-1295-ESGO\u2005The role of intraoperative indocyanine green fluorescence angiography in preventing anastomotic leakage after colorectal resection for advanced ovarian cancer","volume":"32","author":"Schivardi","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0175","article-title":"2022-RA-690-ESGO\u2005Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe","volume":"32","author":"Van der Kolk","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0180","doi-asserted-by":"crossref","first-page":"A89","DOI":"10.1136\/ijgc-2021-003144","volume":"32","author":"Xu","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0185","first-page":"A458","article-title":"2022-RA-1057-ESGO\u2005Outcomes of gynaecological cancer surgery during the covid-19 pandemic: results from the international, multicenter, prospective covidsurg-gynaecological cancer study","volume":"32","author":"Fotopoulou","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004184_bb0190","article-title":"2022-RA-1699-ESGO\u2005ERAS pathway for gynecological oncology \u2013 a pre-post implementation cohort with 1211 patients","volume":"32","author":"Samou\u00eblian","year":"2022","journal-title":"Int J Gynecol Cancer"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24009095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24009095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2022-004184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:40:40Z","timestamp":1753224040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24009095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1048891X24009095"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2022-004184","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Best original research presented at the 23rd European Congress on Gynaecological Oncology\u2014Best of ESGO 2022","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2022-004184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}